TY - JOUR
T1 - Child COVID-19 vaccine uptake among participants of the 2015 Pelotas (Brazil) Birth Cohort Study
AU - Sartori, Ana Lucia
AU - Buffarini, Romina
AU - Machado da Silva, Aline
AU - Amaral de Andrade Leão, Otávio
AU - Ramos Flores, Thaynã
AU - Dâmaso Bertoldi, Andréa
AU - Curi Hallal, Pedro
AU - Freitas da Silveira, Mariângela
N1 - This article is based on data from the study \u201CPelotas Birth Cohort, 2015\u201D conducted by Postgraduate Program in Epidemiology, Federal University of Pelotas . The 2015 Pelotas Birth Cohort Study received funding from the following agencies: Wellcome Trust ( 095582 ), Brazilian Public Health Association (ABRASCO), Brazilian National Council for Scientific and Technological Development (CNPq), Research Support Foundation of the State of Rio Grande do Sul (FAPERGS). Children\u2019s Pastorate sponsored follow-up at 24\u202Fmonths; FAPERGS\u2014PPSUS, the Wellcome Trust (210735_A_18_Z), and the Bernard van Leer Foundation ( BRA-2018-178 ) funded the 4-year follow-up. At the 4\u202Fyears follow-up, the 2015 cohort also was funded by the Department of Science and Technology (DECIT/ Brazilian Ministry of Health ). The 6\u20137\u202Fyears follow-up received funding from the DECIT/Brazilian Ministry of Health), Instituto Todos Pela Sa\u00FAde, Celer Biotecnologia SA, FAPERGS (PqG 21/2551\u20130002004-0 ) and CNPq ( 407813/2021\u20137 , 406582/2021\u20131 and 406582/2021\u20131 ).
The authors thank all the families who participated in the 2015 Pelotas Birth Cohort Study for their involvement, and the Cohort's team, including research scientists, interviewers, workers, and volunteers. The authors would like to thank the Epidemiological Surveillance Team from Pelotas Municipal Health Department for the support to collect data from NIP-IS. This article is based on data from the study \u201CPelotas Birth Cohort, 2015\u201D conducted by Postgraduate Program in Epidemiology, Federal University of Pelotas, Brazil. The 2015 Pelotas Birth Cohort Study received funding from the following agencies: Wellcome Trust (095582), United Kingdom; Brazilian Public Health Association (ABRASCO), Brazil; Brazilian National Council for Scientific and Technological Development (CNPq), Brazil; Research Support Foundation of the State of Rio Grande do Sul (FAPERGS), Brazil. Children's Pastorate, Brazil, sponsored follow-up at 24 months; FAPERGS\u2014PPSUS, the Wellcome Trust (210735_A_18_Z), and the Bernard van Leer Foundation (BRA-2018-178), Netherlands, funded the 4-year follow-up. At the 4 years follow-up, the 2015 cohort also was funded by the Department of Science and Technology (DECIT/Brazilian Ministry of Health), Brazil. The 6\u20137 years follow-up received funding from the DECIT/Brazilian Ministry of Health, Instituto Todos Pela Sa\u00FAde, Brazil; Celer Biotecnologia SA, Brazil; FAPERGS (PqG 21/2551\u20130002004-0) and CNPq (407813/2021\u20137, 406582/2021\u20131 and 406582/2021\u20131). Due to confidentiality restrictions related to the ethics approval for this study, no identifying information about participants may be released. Dataset without identification used during the current study will be made available on request. The study protocol was approved by the Research Ethics Committee at the Federal University of Pelotas (School of Physical Education: 0-4 years, #26746414.5.0000.5313. Medical School: 6-7 years follow-up, #51789921.1.0000.5317). The children's parents or legal representatives signed an informed consent form before each interview, including a statement authorizing the investigators to check their data on official health information systems, such as National Immunization Program Information System (NIP-IS) of the Brazilian Unified Health System (SUS for short, in Portuguese).
PY - 2024/10/24
Y1 - 2024/10/24
N2 - Objective: To analyze COVID-19 vaccine uptake in children and to investigate factors associated with two outcomes variables: (a) not even beginning; (b) not completing the COVID-19 vaccine series. Methods: We used data of children aged 6–7 years from the 2015 Pelotas c Birth Cohort Study. COVID-19 vaccination status was collected from immunization cards and National Immunization Program Information System. Adjusted analyses were performed using a hierarchical model to identify factors associated with the two study outcomes. Results: Among 3867 children, 20.7 % (95 % CI, 19.5 %–22.0 %) did not even begin the 2-dose primary COVID-19 vaccine series, and 28.2 % (95 % CI, 26.6 %–29.8 %) did not complete the series with the second dose. Children not even beginning the COVID-19 vaccine series were more likely to have a White mother, not to have obesity, to have a history of COVID-19 infection, to have received non-recommended drugs for COVID-19, to be afraid of needles, and to have an incomplete diphtheria-tetanus-pertussis (DTP) and poliovirus immunization schedule. Not completing the 2-dose series was associated with lower maternal age and education, mother's self-identification as White or Brown, lower household income, lack of access to health services, not having completed the DTP and poliovirus immunization schedule and living with a person with a history of infection with COVID-19. Conclusion: The results highlight a vaccine-hesitant parents’ group who chose not beginning the COVID-19 vaccine series of their children and, another group of parents who failure to complete the child's series due to difficulty accessing health services.
AB - Objective: To analyze COVID-19 vaccine uptake in children and to investigate factors associated with two outcomes variables: (a) not even beginning; (b) not completing the COVID-19 vaccine series. Methods: We used data of children aged 6–7 years from the 2015 Pelotas c Birth Cohort Study. COVID-19 vaccination status was collected from immunization cards and National Immunization Program Information System. Adjusted analyses were performed using a hierarchical model to identify factors associated with the two study outcomes. Results: Among 3867 children, 20.7 % (95 % CI, 19.5 %–22.0 %) did not even begin the 2-dose primary COVID-19 vaccine series, and 28.2 % (95 % CI, 26.6 %–29.8 %) did not complete the series with the second dose. Children not even beginning the COVID-19 vaccine series were more likely to have a White mother, not to have obesity, to have a history of COVID-19 infection, to have received non-recommended drugs for COVID-19, to be afraid of needles, and to have an incomplete diphtheria-tetanus-pertussis (DTP) and poliovirus immunization schedule. Not completing the 2-dose series was associated with lower maternal age and education, mother's self-identification as White or Brown, lower household income, lack of access to health services, not having completed the DTP and poliovirus immunization schedule and living with a person with a history of infection with COVID-19. Conclusion: The results highlight a vaccine-hesitant parents’ group who chose not beginning the COVID-19 vaccine series of their children and, another group of parents who failure to complete the child's series due to difficulty accessing health services.
KW - COVID-19
KW - Immunization coverage
KW - SARS-CoV-2 vaccine
KW - Vaccination hesitancy
KW - Vaccination, Cohort studies
KW - Vaccine pediatric cohort
UR - http://www.scopus.com/inward/record.url?scp=85198137991&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85198137991&partnerID=8YFLogxK
U2 - 10.1016/j.vaccine.2024.07.006
DO - 10.1016/j.vaccine.2024.07.006
M3 - Article
C2 - 38991916
AN - SCOPUS:85198137991
SN - 0264-410X
VL - 42
JO - Vaccine
JF - Vaccine
IS - 24
M1 - 126105
ER -